U of M startup CoreBiome has partnered with a clinical-stage biotech company to harness the health potential of gut microbes.
Under an agreement announced this month, CoreBiome – which is based in St. Paul’s St. Anthony Park neighborhood – will perform its proprietary “BoosterShot” gene-sequencing service on tens of thousands of biological samples for Kaleido Biosciences in Bedford, Mass.
Read the full story in the Star Tribune.